simvastatin has been researched along with Cardiac Arrest, Sudden in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blazing, MA; Braunwald, E; Clare, RM; Fanaroff, AC; Giugliano, RP; Lokhnygina, Y; Navar, AM; Roe, MT; Tershakovec, AM; Wiviott, SD | 1 |
| Boman, K; Devereux, RB; Gerdts, E; Gohlke-Baerwolf, C; Greve, AM; Køber, L; Ray, S; Rossebø, AB; Wachtell, K; Willenheimer, R | 1 |
| Origasa, H; Yokoyama, M | 1 |
| Pederson, JP; Weintraub, WS | 1 |
| Hanyecz, V; Kondacs, A; Márk, L; Simondán, G | 1 |
4 trial(s) available for simvastatin and Cardiac Arrest, Sudden
| Article | Year |
|---|---|
Competing Risks of Cardiovascular Versus Noncardiovascular Death During Long-Term Follow-Up After Acute Coronary Syndromes.
Topics: Acute Coronary Syndrome; Age Distribution; Aged; Cause of Death; Death, Sudden, Cardiac; Dose-Response Relationship, Drug; Double-Blind Method; Ezetimibe; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Prognosis; Risk Assessment; Risk Factors; Sex Distribution; Simvastatin; Survival Rate; Time Factors; United States | 2017 |
HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment.
Topics: Arterial Occlusive Diseases; Chemical and Drug Induced Liver Injury; Death, Sudden, Cardiac; Delayed-Action Preparations; Drug Therapy, Combination; Female; Humans; Hypolipidemic Agents; Indoles; Male; Middle Aged; Muscular Diseases; Myocardial Infarction; Myocardial Reperfusion; Niacin; Simvastatin; Stroke | 2013 |
Impact of QRS duration and morphology on the risk of sudden cardiac death in asymptomatic patients with aortic stenosis: the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study.
Topics: Aged; Aged, 80 and over; Aortic Valve Stenosis; Azetidines; Bundle-Branch Block; Death, Sudden, Cardiac; Electrocardiography; Ezetimibe; Female; Humans; Male; Middle Aged; Predictive Value of Tests; Prognosis; Simvastatin | 2012 |
Effects of eicosapentaenoic acid on cardiovascular events in Japanese patients with hypercholesterolemia: rationale, design, and baseline characteristics of the Japan EPA Lipid Intervention Study (JELIS).
Topics: Adult; Aged; Angina, Unstable; Anticholesteremic Agents; Chemotherapy, Adjuvant; Coronary Artery Disease; Death, Sudden, Cardiac; Eicosapentaenoic Acid; Fatty Acids, Unsaturated; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Japan; Male; Middle Aged; Myocardial Infarction; Pravastatin; Prospective Studies; Simvastatin | 2003 |
3 other study(ies) available for simvastatin and Cardiac Arrest, Sudden
| Article | Year |
|---|---|
[Stable coronary heart disease--lessons from the COURAGE Study. With intensive drug therapy on the success track].
Topics: Angioplasty, Balloon, Coronary; Anticholesteremic Agents; Azetidines; Cardiovascular Agents; Combined Modality Therapy; Coronary Disease; Coronary Stenosis; Death, Sudden, Cardiac; Ezetimibe; Humans; Kaplan-Meier Estimate; Life Style; Multicenter Studies as Topic; Myocardial Infarction; Outcome and Process Assessment, Health Care; Randomized Controlled Trials as Topic; Simvastatin | 2008 |
Atherosclerosis and restenosis: reflections on the Lovastatin Restenosis Trial and Scandinavian Simvastatin Survival Study.
Topics: Angioplasty, Balloon, Coronary; Anticholesteremic Agents; Coronary Artery Disease; Death, Sudden, Cardiac; Humans; Lovastatin; Myocardial Infarction; Pravastatin; Randomized Controlled Trials as Topic; Recurrence; Scandinavian and Nordic Countries; Simvastatin; Survival Analysis | 1996 |
[Data on cholesterol level screening of patients with ischemic heart disease in the light of the Scandinavian Simvastatin Survival Study].
Topics: Adult; Aged; Anticholesteremic Agents; Cholesterol; Death, Sudden, Cardiac; Drug Costs; Female; Humans; Hungary; Hypercholesterolemia; Lovastatin; Male; Mass Screening; Middle Aged; Myocardial Ischemia; Prevalence; Risk Factors; Scandinavian and Nordic Countries; Simvastatin; Survival Rate | 1997 |